HealthyWomen.org
Call Us: 1-877-986-9472 (toll-free)
      Spell Checker
Health Topics A-Z Sign up for Free e-Newsletters
Related Resources
 
Books (4)
News (7)
National Organizations (7)
Web Sites (14)
NWHRC Publications (1)
 
Health Topics A-Z
 
Table of Contents
 
 
Health Topics A-ZText size: A A A December 1, 2008

References

Health Topics
order nwhrc publications

Basson, Rosemary. "The Female Sexual Response: A Different Model." Journal of Sex & Marital Therapy, 26:51-65, 2000.

Zestra. Zestra.com. http://www.zestraforwomen.com. Accessed December 9, 2004.

"Recommendations for estrogen and progesogen use in peri- and postmenopausal women: October 2004 position states of the North American Menopause Society." Menopause (The Journal of NAMS) 2004 11;6:589-600. Available at http://www.menopause.org. Accessed December 9, 2004.

"FDA Plans to Evaluate Results of Women's Health Initiative Study for Estrogen-Alone Therapy." U.S. Food and Drug Administration. "FDA Talk Paper." March 2, 2004. http://www.fda.gov. Accessed December 9, 2004.

"FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data." FDA News/Press Release. January 8, 2003. http://www.fda.gov. Accessed December 9, 2004.

Lacey, James V., et al. "Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer." JAMA 2002; 288:334-341.368-369.

Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.

Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.

Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.

"NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit." National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. July 9, 2002. Accessed December 9, 2004.

"Findings from the WHI Postmenopausal Hormone Therapy Trials." Women's Health Initiative, National Heart, Lung and Blood Institute. National Institutes of Health. http://www.nhlbi.nih.gov. Accessed December 9, 2004.

Ricardo Manuel Munarriz, Lily Talakoub, Nancy Lahey, Melissa Gioia, Aleksander Chudnovsky, Elise De, Irwin Goldstein. Boston University, Boston, MA. "Hormone, Sexual Function and Personal Sexual Distress (SDS) Outcomes Following Dehydroepiandrosterone (DHEA) Treatment for Female Sexual Dysfunction (FSD) and Androgen Deficiency Syndrome (ADS)" Poster session presented at the 2001 American Urological Association annual meeting.

Menopause Guidebook: Helping Women Make Informed Healthcare Decisions through Perimenopause and Beyond. North American Menopause Society: May 2003. http://www.menopause.org. Accessed December 9, 2004.

"Androgen." Health Center Topic. National Women's Health Resource Center. http://www.healthywomen.org. Accessed Eecember 9, 2004.

"Androgen Replacement No Panacea for Women's Libido." American College of Obstetricians and Gynecologists. News release. Oct. 31, 2000. http://www.acog.org. Accessed December 9, 2004.

Berman, J, and Berman, L. "Female Sexual Dysfunction: Definitions, Causes & Potential Treatments." Network for Excellence in Women's Sexual Health. http://www.newshe.com. Accessed December 9, 2004.

"Consumer Update: Female Sexual Problems." American Association for Marriage and Family Therapy. Updated Sepember 13, 2004. http://www.aamft.org. Accessed December 9, 2004.

"Estrogen." Health Center Topic. National Women's Health Resource Center. http://www.healthywomen.org. Accessed December 9, 2004.

Fact Sheets. Network for Excellence in Women's Sexual Health. http://www.newshe.com. Accessed December 9, 2004.

"FDA Clears New Female Sexual Therapy Device." U.S. Food and Drug Administration. Talk Paper. May 3, 2000. http://www.fda.gov. Accessed December 9, 2004.

"Sexual Dysfunction-- Silence About Sexual Problems Can Hurt Relationships." JAMA Patient Page. Journal of the American Medical Association. Available through Medem-Connecting Physicians and Patients. Feb. 1999. http://www.medem.com. Accessed December 9, 2004.

"Sexuality and Sexual Problems." American College of Obetricians and Gynecologists. Available through Medem - Connecting Physicians and Patients. http://www.medem.com. Accessed December 9, 2004.

"Latest Report on Test of Viagra on Women." Based on Basson R, McInnes R, Smith M, et. al. Efficacy and safety of Viagra in estrogenized women with sexual dysfunction associated with female sexual arousal disorder. Poster session presented at the American College of Obstetricians and Gynecologists annual meeting in San Francisco. May 23, 2000.

Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281(6):537-544.

"Mature Sexuality Clinical Proceedings. "Female Sexual Dysfunction." Association of Reproductive Health Professionals. Updated April 8, 2002. http://www.arhp.org. Accessed December 9, 2004.

"Menopause." " Mayo Clinic.com. October 21, 2003. http://www.mayoclinic.com. Accessed December 9, 2004.

Merck & Co. The Merck Manual of Diagnosis and Therapy. Section 18, Gynecology and Obstetrics; Chapter 243. Sexual Dysfunction in Women. http://www.merck.com. Accessed December 9, 2004.

Murdock, M. "Comments on the Viagra Study on Estrogenized Women." hisandherhealth.com http://www.hisandherhealth.com. Accessed December 9, 2004.

"Pain During Intercourse." The American College of Obstetricians and Gynecologists, Available through Medem-Connecting Physicians and Patients. Copyright 1999. . http://www.medem.com. Accessed December 9, 2004.

"Perimenopause: Pathways to Change." Updated October 30, 2004. Association of Reproductive Health Professionals. http://www.arhp.org. Accessed December 9, 2004.

"Restoring Sexual Health." Consumer Reports On Health. 2001 March; 13(3): 8-10.

Rosen, RC. Prevalence and risk factors of sexual dysfunctions in men and women, Current Psychiatric Reports 2000 June; 2(3): 189-195. Abstract available at Medline/PubMed. http://www.ncbi.nlm.nih.gov. Accessed December 9, 2004.

Rosenbaum, MB, and O'Hanlan, KA. Chapter 12, Sexuality. In The Woman's Complete Healthbook of the American Medical Women's Association. Delacorte Press, New York: 1995.

Sexuality and Sexual Problems. The American College of Obstetricians and Gynecologists Washington, DC. April 2000.

Figueira I, Possidente E, Marques C, Hayes K. Sexual dysfunction: a neglected complication of panic disorder and social phobia. Arch Sex Behav 2001 Aug; 30(4):369-377

"Drugs may not cure female sexual dysfunction." Obstetrics & Gynecology 2001; 98:350-353.

"Masters and Johnson's Human Sexual Response Cycle." http://www.csupomona.edu. Accessed September 2006.

"Female Lack of Desire." The Association of Reproductive Health Professionals. http://www.arhp.org. Accessed September 2006.

"Patient information: Sexual problems in women." Uptodate.com. April 2006. http://patients.uptodate.com. Accessed October 2006.

"Sexual dysfunction in the United States, Prevalence and Predictors." JAMA. 1999;281:537-544. http://www.pubmedcentral.nih.gov. Accessed October 2006.

"Clinical study results." Eros therapy. 2006. http://www.eros-therapy.com. Accessed October 2006.

"Frequently asked questions about hormone therapy." The American College of Obstetricians and Gynecologists. October 2004. http://www.acog.org. Accessed October 2006.

 
View References for this Health Topic Create Date: 4/1/02
Date Last Updated: 3/8/07
Review Date: 2/15/07
 
  Email this Page Email this Page
Sign up for Free E-Newsletters Print this Page Print this Page
ORDER PUBLICATIONS |  FREE E-NEWSLETTERS |  RSS FEEDS |  SITE MAP |  CONTACT US
National Women's Health Resource Center   157 Broad Street, Suite 106   Red Bank, NJ 07701   1-877-986-9472 (toll-free)